Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- Status
- RECRUITING
- Phase
- N/A
A Study of the Change in Early and Sustained Pain Control in Axial Spondylarthritis in Adult Participants Receiving Upadacitinib
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age
- Status
- COMPLETED
- Phase
- PHASE3
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access to Telisotuzumab Vedotin
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Volatile Organic Compounds (VOCs) in Active Inflammatory Bowel Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- N/A
Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of Migraine
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Change in Disease State When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Taiwan
- Status
- COMPLETED
- Phase
- N/A
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis
- Status
- TERMINATED
- Phase
- PHASE1
Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell Cancers
- Status
- TERMINATED
- Phase
- PHASE1
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting
- Status
- WITHDRAWN
- Phase
- N/A
Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)
- Status
- COMPLETED
- Phase
- PHASE1
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Psoriasis Treated With Subcutaneous Risankizumab Injection According to Standard of Care
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Status
- RECRUITING
- Phase
- PHASE3